[1]
S. R. Salih, A. Majeed, K. Hussein, Y. Yasin, and A. Jumaa, “Dual Drug Repurposing in Cervical Cancer: The Synergistic Cytotoxic Effect of Dapagliflozin-Etoricoxib and Its Predicted Modulation of PI3K/Akt/mTOR Signaling via Molecular Docking”, apjcb, vol. 10, no. 4, pp. 821-835, Oct. 2025.